BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 18577116)

  • 1. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
    Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
    Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of triple malignancies (gastric cancer, lung cancer and malignant pleural mesothelioma) after asbestos exposure].
    Kishimoto T
    Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):304-9. PubMed ID: 12795187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal cell carcinoma with malignant pleural mesothelioma after asbestos exposure: a case report].
    Sawazaki H; Yoshikawa T; Takahashi T; Taki Y; Takeuchi H; Sakai Y
    Hinyokika Kiyo; 2007 Nov; 53(11):805-8. PubMed ID: 18051806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma.
    Saito R; Kasajima A; Taniuchi S; Fujishima F; Ishida K; Nakamura Y; Yamanda S; Takahashi T; Hitomi H; Murakami K; Watanabe M; Sasano H
    Pathol Int; 2012 Oct; 62(10):709-15. PubMed ID: 23005599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Small-cell mesothelioma of the pleura: description of a case].
    Cavazza A; Rossi G; Agostini L; Facciolongo N; De Marco L; Putrino I; Gardini G
    Pathologica; 2002 Oct; 94(5):247-52. PubMed ID: 12417972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
    Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma.
    Imenpour H; Ivaldi GP; Brianti A; Pastorino G; Biggi S; Auriati L; Simonassi C
    Pathologica; 2013 Dec; 105(6):353-6. PubMed ID: 24730341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
    Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
    Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistent atypical adenomatous hyperplasia, primary lung adenocarcinoma and pleural mesothelioma in an asbestos-exposed subject.
    Thomas DH; Attanoos RL; Gibbs AR
    Histopathology; 2004 Nov; 45(5):540-2. PubMed ID: 15500660
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?
    Deniz H; Kibar Y; Güldür ME; Bakir K
    Pathol Res Pract; 2009; 205(11):749-52. PubMed ID: 19573998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mesothelioma masquerading as a multinodular bronchioloalveolar cell adenocarcinoma with widespread pulmonary nodules.
    Felner KJ; Wieczorek R; Kline M; Smith RL; Sidhu GS
    Int J Surg Pathol; 2006 Jul; 14(3):229-33. PubMed ID: 16959710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis between mesothelioma and adenocarcinoma: a multimodal approach based on ultrastructure and immunocytochemistry.
    Bedrossian CW; Bonsib S; Moran C
    Semin Diagn Pathol; 1992 May; 9(2):124-40. PubMed ID: 1609155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of pericardial malignant mesothelioma accompanied by primary lung adenocarcinoma].
    Nojiri S; Yumino Y; Sato K; Onodera R; Nakayama K; Kuwano K
    Nihon Kokyuki Gakkai Zasshi; 2009 Feb; 47(2):104-9. PubMed ID: 19260532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudomesotheliomatous carcinoma of the lung].
    Maeda R; Isowa N; Kawasaki Y; Tokuyasu H; Itakura A; Miura H; Onuma H
    Kyobu Geka; 2007 Jul; 60(7):555-8. PubMed ID: 17642217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
    Takeshima Y; Amatya VJ; Kushitani K; Kaneko M; Inai K
    Histopathology; 2009 May; 54(6):667-76. PubMed ID: 19438742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
    Attanoos RL; Thomas DH; Gibbs AR
    Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pleuropulmonary tumors. Presentation of 2 cases with peculiar clinicopathologic traits].
    Esquius Soriguera J; Alejo Sánchez M; Padilla Navas I; Rodríguez Casquero C; León González C
    Rev Clin Esp; 1989 Oct; 185(6):303-5. PubMed ID: 2623239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.